For MRP1, high levels of the gene were associated with poor prognosis and high histological grade in childhood neuroblastoma [40–42], soft tissue sarcoma [43], and non-small cell lung cancer [44–46], and with recurrence in breast cancer patients who were treated with chemotherapy [47]. This evidence concerns the gene ABCC1 and breast carcinoma.